Skip to main content
Translational Oncology logoLink to Translational Oncology
. 2021 Oct 3;14(12):101226. doi: 10.1016/j.tranon.2021.101226

Corrigendum to “Chemotherapy Modulates Endocrine Therapy-Related Resistance Mutations in Metastatic Breast Cancer” [Translational Oncology (2019) 12, 764–774]

Dabo Zhou *,†,, Liping Liu *,†,, Jingyu Liu *,†,, Yu Tang *,†,, Mengjia Xiao *,†,, Yikai Wang §, Qiongzhi He , Zhe-Yu Hu *,†,‡,1, Quchang Ouyang *,†,‡,1
PMCID: PMC8498458  PMID: 34614466

The authors regret that “they missed an important funding of Hunan Key Research Project No. 2018SK2124 (Quchang Ouyang) from Department of Science and Technology of Hunan Province (CN). The funding supported the study design, data collection and the publication”. The authors apologize for any confusion.

Contributor Information

Zhe-Yu Hu, Email: jennydavid@163.com.

Quchang Ouyang, Email: oyqc1969@126.com.


Articles from Translational Oncology are provided here courtesy of Neoplasia Press

RESOURCES